JAK inhibitors and other oral immunology drugs on Humana Value Rx Plan (S5884-202)
Rinvoq, Xeljanz, Olumiant and Otezla, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Oklahoma
- Premium
- $33.70/month
- Deductible
- $601.00, doesn't apply to tier 1 and 2
1 of 5 JAK inhibitors is covered on this plan. It requires prior authorization.
4 aren't on the formulary, including Xeljanz and Olumiant.
- from $1,664.76Tier 5
Not on the formulary
Xeljanz, Olumiant, Otezla, Sotyktu
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $601.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.